Survey on Drugs and its Metabolites


Journal of Developing Drugs is an open access Scientific Journal which mainly focuses on articles of Drug designing. The Journal of Developing Drugs comes up with an opportunity to researchers and scientist to explore advance research in Drug Development. The Journal of Developing Drugs is of highest standards in terms of quality.


The editorial team of Developing Drugs and Research is overwhelmed by the response and eagerness of the academic and research contributors to publish with the journal. During this year we look forward to taking some initiates that would encourage and reward our prospective customers. It gives us great pleasure in announcing the call for paper at special and hefty discount of up to 30 percent on one-time article processing charge.


Developing Drugs journals have been showing tremendous citations and articles focusing the most advanced research trends in the field Drug Interactions, Medicinal Chemistry, Drug Metabolism, Drug discovery, Drug Designing, OTC Drugs and Pharmaceutical Drugs. Journal of Developing Drugs impact factors is mainly calculated based on the number of articles that undergo single blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles.


A standard Editorial Tracking system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded via Editorial system or can be forwarded to the editorial office at ; 


After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision.

The journal publishes the articles under open access policy with creative commons attribution license [CC-BY-NC 4.0] permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

In addition to archiving, the published articles are also promoted through various scientific and social media as well as through International indexation and abstracting services.

Feel free for contact us for any query.


With kind regards,

Angelina Jonas PhD
Managing Editor
Journal of Developing Drugs
Whatsapp: +3225889658